- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT02039141
Diabetes Prevention Program for Obese Latino Youth (ELSC)
Community-Based Diabetes Prevention Program for Obese Latino Youth: Every Little Step Counts
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
Obesity in the United States has reached epidemic proportions and Latinos youth are disproportionally impacted. Pediatric obesity is associated with several chronic health conditions including insulin resistance and type 2 diabetes. However, very few interventions specifically targeting diabetes prevention for obese Latino adolescents have been developed.
Therefore, the purpose of this study is to examine the effects a culturally-grounded, community-based lifestyle intervention on psychosocial and health outcomes among obese Latino adolescents. Eligible participants of this study will be randomly selected to the intervention group or the delayed-intervention group (control group) after an initial health screening for eligibility.
Participants selected to the intervention group will attend weekly healthy lifestyle education sessions with their parent(s)/guardian(s) and three physical activity sessions / week with other youth. After which, participants will attend monthly booster group meetings for three months.
All participants will be assessed at baseline, 3 months, 6 months, and 12 months for insulin sensitivity, glucose tolerance, quality of life, fitness, and nutrition and physical activity behaviors.
Studientyp
Einschreibung (Tatsächlich)
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
Arizona
-
Phoenix, Arizona, Vereinigte Staaten, 85003
- Arizona State University
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- Latino: self-report by parents
- Age: 14-16
- Obese: BMI percentile >= 95th percentile for age and gender or BMI >= 30 kg/m^2
Exclusion Criteria:
- Taking medication(s) or diagnosed with a condition that could influence carbohydrate metabolism, physical activity, and/or cognition
- Type 2 diabetes: Fasting plasma glucose >= 126 mg/dL or 2-hour plasma glucose >= 200 mg/dL (youth found to be diabetic through study's procedures will be referred for follow up care and excluded)
- Recent hospitalizations (previous 2 months)
- Currently enrolled in (or with in previous 6 months) a formal weight loss program
- Diagnosed depression or other condition that may impact QoL
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Verhütung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Keine (Offenes Etikett)
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: Every Little Step Counts Intervention
Exercise classes (3/week) Lifestyle sessions (1/week)
|
Youth participants randomized to participate in the experimental group will attend weekly healthy lifestyles education session with their parent(s)/guardian(s) and will also attend exercise sessions 3 times a week for 12 weeks.
The education sessions will cover topics such as healthy eating choices, roles and responsibilities of both parents and youth in the realm of the family unit as well as in youth's own health, and self esteem among other topics.
The exercise sessions will incorporate both aerobic and resistance training as well as other "free-play" physical activities i.e. basketball, volleyball etc.
Andere Namen:
|
|
Kein Eingriff: Delayed ELSC Intervention Group
Control group (delayed intervention group)
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Change in Insulin Sensitivity / Glucose Tolerance, Measured at Baseline, Change 3-months, 6-months, and 12-months
Zeitfenster: Baseline, 3 months after baseline, 6 months after baseline, 12 months after baseline
|
Proximal indicator of diabetes risk
|
Baseline, 3 months after baseline, 6 months after baseline, 12 months after baseline
|
|
Change in Quality of Life Measured at Baseline, 3-months, 6-months, and 12-months
Zeitfenster: Baseline, 3 months after baseline, 6 months after baseline, 12 months after baseline
|
Generic and weight-specific quality of life
|
Baseline, 3 months after baseline, 6 months after baseline, 12 months after baseline
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Change in Self efficacy for healthy eating and exercise
Zeitfenster: Baseline, 3 months after baseline, 6 months after baseline, 12 months after baseline
|
These secondary outcomes measures aim to explore the mechanisms of the intervention by assessing the "mediated effect" on the outcomes of insulin sensitivity and weight-specific QoL through the following putative mediators targeted in the program: self-efficacy for healthy eating and exercise.
|
Baseline, 3 months after baseline, 6 months after baseline, 12 months after baseline
|
|
Change in Social support from family and friends on healthy eating and exercise.
Zeitfenster: Baseline, 3 months after baseline, 6 months after baseline, 12 months after baseline
|
These secondary outcomes measures aim to explore the mechanisms of the intervention by assessing the "mediated effect" on the outcomes of insulin sensitivity and weight-specific QoL through the following putative mediators targeted in the program: Social support from family and friends on healthy eating and exercise.
|
Baseline, 3 months after baseline, 6 months after baseline, 12 months after baseline
|
Andere Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Initial incremental cost effectiveness of intervention vs. standard care
Zeitfenster: Analysis for the outcome is expected to occur approximately 4 years after the initial baseline testing. Data for analysis will be consist of one year ELSC cost.
|
Analysis will be conducted on the initial incremental cost effectiveness of the intervention compared to no intervention on changes in insulin sensitivity and prevention of diabetes.
|
Analysis for the outcome is expected to occur approximately 4 years after the initial baseline testing. Data for analysis will be consist of one year ELSC cost.
|
Mitarbeiter und Ermittler
Sponsor
Mitarbeiter
Ermittler
- Hauptermittler: Gabriel Q Shaibi, PhD, Arizona State University
Publikationen und hilfreiche Links
Allgemeine Veröffentlichungen
- Williams AN, Konopken YP, Keller CS, Castro FG, Arcoleo KJ, Barraza E, Patrick DL, Olson ML, Shaibi GQ. Culturally-grounded diabetes prevention program for obese Latino youth: Rationale, design, and methods. Contemp Clin Trials. 2017 Mar;54:68-76. doi: 10.1016/j.cct.2017.01.004. Epub 2017 Jan 16. Erratum In: Contemp Clin Trials. 2018 Aug;71:205.
- Soltero EG, Olson ML, Williams AN, Konopken YP, Castro FG, Arcoleo KJ, Keller CS, Patrick DL, Ayers SL, Barraza E, Shaibi GQ. Effects of a Community-Based Diabetes Prevention Program for Latino Youth with Obesity: A Randomized Controlled Trial. Obesity (Silver Spring). 2018 Dec;26(12):1856-1865. doi: 10.1002/oby.22300. Epub 2018 Nov 14.
- Olson ML, Renteria-Mexia A, Connelly MA, Vega-Lopez S, Soltero EG, Konopken YP, Williams AN, Castro FG, Keller CS, Yang HP, Todd MW, Shaibi GQ. Decreased GlycA after lifestyle intervention among obese, prediabetic adolescent Latinos. J Clin Lipidol. 2019 Jan-Feb;13(1):186-193. doi: 10.1016/j.jacl.2018.09.011. Epub 2018 Sep 22.
- Renteria-Mexia A, Vega-Lopez S, Olson ML, Swan PD, Lee CD, Williams AN, Shaibi GQ. Effects of a lifestyle intervention on markers of cardiometabolic risk and oxidized lipoproteins among obese adolescents with prediabetes. Public Health Nutr. 2019 Mar;22(4):706-713. doi: 10.1017/S1368980018003476. Epub 2018 Dec 27.
Nützliche Links
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Tatsächlich)
Studienabschluss (Tatsächlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Schätzen)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- 1203007572
- 5P20MD002316-07 (US NIH Stipendium/Vertrag)
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Every Little Step Counts Intervention
-
NYU Langone HealthNational Institutes of Health (NIH)Noch keine Rekrutierung
-
University of WarwickUniversity of BirminghamAbgeschlossen
-
University of Wisconsin, MilwaukeeMedical College of Wisconsin; Children's Hospital and Health System Foundation... und andere MitarbeiterAbgeschlossenJunger Erwachsener, Krebs, körperliche AktivitätVereinigte Staaten
-
The University of Hong KongAbgeschlossenGebrechlichkeit | GeriatrieHongkong
-
Singapore General HospitalChangi General Hospital; National Medical Research Council (NMRC), Singapore; Duke-NUS...Aktiv, nicht rekrutierendPanikattacken und StörungenSingapur
-
University of MiamiNational Institute of Mental Health (NIMH); Massachusetts General HospitalAbgeschlossen
-
Albert Einstein College of MedicineHealth Resources and Services Administration (HRSA); The New SchoolAbgeschlossenHäusliche Gewalt | KindesmisshandlungVereinigte Staaten
-
Peking UniversityRekrutierungDepression | Streicheln | Rehabilitation | InterventionChina
-
The University of Tennessee, KnoxvilleNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Abgeschlossen
-
State University of New York at BuffaloNational Institute on Alcohol Abuse and Alcoholism (NIAAA)AbgeschlossenAlkoholabhängigkeit | AlkoholmissbrauchVereinigte Staaten